Centerpoint Advisors’s LeMaitre Vascular LMAT Stock Holding History

Centerpoint Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25K	Hold	228	–	–	0.01%	207
2025 Q4	$18K	Hold	228	–	–	0.01%	272
2025 Q3	$20K	Sell	228 -1	-0.4%	-$89	0.01%	254
2025 Q2	$19K	Hold	229	–	–	0.01%	252
2025 Q1	$19K	Sell	229 -17,526	-99%	-$1.63M	0.01%	249
2024 Q4	$1.64M	Hold	17,755	–	–	0.57%	22
2024 Q3	$1.65M	Hold	17,755	–	–	0.57%	22
2024 Q2	$1.46M	Sell	17,755 -38	-0.2%	-$2.79K	0.53%	25
2024 Q1	$1.18M	Hold	17,793	–	–	0.44%	29
2023 Q4	$1.01M	Hold	17,793	–	–	0.4%	31
2023 Q3	$969K	Sell	17,793 -4	-0%	-$237	0.41%	32
2023 Q2	$1.2M	Hold	17,797	–	–	0.49%	28
2023 Q1	$916K	Buy	17,797 +17,484	+5,586%	+$849K	0.4%	32
2022 Q4	$14K	Buy	+313	New	+$14.7K	0.01%	264

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Centerpoint Advisors's LMAT Position: Q1 2026 in Review

Centerpoint Advisors held its LeMaitre Vascular (LMAT) position steady in Q1 2026 at 228 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #207.

Centerpoint Advisors first reported a position in LMAT in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.65M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Centerpoint Advisors held 228 shares of LeMaitre Vascular worth $25K as of Q1 2026.
Centerpoint Advisors left its LeMaitre Vascular share count unchanged in Q1 2026.
LeMaitre Vascular made up 0.01% of Centerpoint Advisors's portfolio in Q1 2026, its #207 holding.
Centerpoint Advisors first reported a position in LeMaitre Vascular in Q4 2022 and has held it in 14 quarters since.
Centerpoint Advisors's LeMaitre Vascular position peaked at $1.65M in Q3 2024.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Centerpoint Advisors's 13F filing for Q1 2026, filed 7 May 2026.